Contributing Third Party AgreementContributing Third Party Agreement • May 26th, 2020
This document has been provided to you for the purpose of assessing the opportunity to submit a Programme Proposal to the European Lead Factory for a screening programme within the framework of the ESCulab Grant.
Rights and obligations for Contributing Third PartiesContributing Third Party Agreement • May 13th, 2019
Rewards Obligations uHTS or Phenotypic Screening against unique ESCulab Compound Collection (ECC) Access rights and dissemination (IMI2 IP Framework) Full control of target programme progression Compensation to consortium members within ESCulab in case of direct exploitation Access rights and 3-year exclusivity to exploit QHL results First option right to EFPIA consortium members to license your Programme for direct exploitation (to be negotiated at your discretion)
